FDA Clearance Tracker · P970038-S012
ACCESS HYBRITECH FREE PSA ASSAY
Last checked: Nov 20, 2026Latest source record: Aug 13, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Aug 13, 2008
Approved
Time to decision
78 days
Received May 27, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970038-S012
- Device name
- ACCESS HYBRITECH FREE PSA ASSAY
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Brea, CA
- Received
- May 27, 2008
- Decided
- Aug 13, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970038
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ADDITION OF A CALIBRATION TRACEABLE TO THE WORLD HEALTH ORGANIZATION 1ST INTERNATIONAL REFERENCE PREPARATION 96/668 FOR THE ACCESS HYBRITECH FREE PSA ASSAY
Source documents
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access BNP II510(k)
K262597 · Decided Oct 20, 2026 · 85 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.